| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.038 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.007 | 0.8 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |